Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Vasomax enters pivotal trials

Nov. 15, 1996

PKC inhibitors from Lilly for various therapeutic indications

Nov. 15, 1996

Wyeth-Ayerst withdraws diabetes drug from markets worldwide

Nov. 15, 1996

Imidazoline compound reported as lead for oral hypoglycemic agents

Nov. 15, 1996

Takeda describes potential antidiabetic agents

Nov. 15, 1996

Hyperparathyroidism Rx from NPS effective in dialysis patients

Nov. 15, 1996

Latest findings on the diagnosis and treatment of erectile dysfunction

Nov. 15, 1996

New formulation of Leukine approved by FDA

Nov. 15, 1996

Obesity research collaboration announced by Novo Nordisk and Boehringer Ingelheim

Nov. 15, 1996

Symphony receives grant related to HMG-CoA inhibitors

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...